FDA Approves Aristada Initio for Same-Day Schizophrenia Treatment - MD Magazine

MD MagazineFDA Approves Aristada Initio for Same-Day Schizophrenia TreatmentMD MagazineAt the American Psychiatric Association's annual meeting in May 2018, Walling spoke of the Aristada Initio nanocrystal delivery system and how important the same-day initiation option is for patients with schizophrenia who may have challenges in taking ...FDA OK's 1-Day Initiation for Long-Acting Injectable Schizophrenia TxMedPage Todayall 14 news articles »